Related Experiment Videos
Ovarian metastasis from cervical carcinoma
1Department of Obstetrics and Gynecology, Veterans General Hospital, Taipei, Taiwan.
Summary
Ovarian metastasis is a poor prognostic sign for cervical cancer, regardless of stage or histology. Survival is poor, with lymphatic spread and transtubal implantation being likely metastatic routes.
Area of Science:
- Gynecologic Oncology
- Pathology
- Surgical Oncology
Background:
- Ovarian metastasis from cervical carcinoma is a rare but significant clinical event.
- Understanding the prognosis and metastatic pathways is crucial for patient management.
Purpose of the Study:
- To investigate the prognosis and metastatic routes of cervical carcinoma with ovarian metastasis.
- To analyze the impact of ovarian metastasis on survival outcomes in cervical cancer patients.
Main Methods:
- Retrospective analysis of 1507 cervical carcinoma patients operated between 1980 and 1993.
- Detailed review of 10 cases with confirmed ovarian metastasis, including histology, staging, and treatment data.
Main Results:
- Ovarian metastasis occurred in 10 patients (mean age 45), with 6 squamous cell carcinomas and 4 adenocarcinomas.
- Nodal metastasis was present in 6 of 9 patients who underwent pelvic lymphadenectomy.
- None of the patients survived beyond 5 years; mean survival was 20.8 months for squamous cell and 29 months for adenocarcinoma.
- Corpus involvement was noted in 5 patients, potentially potentiating metastatic spread.
Conclusions:
- Ovarian metastasis is an ominous sign in cervical cancer, irrespective of the initial stage.
- Prognosis for squamous cell carcinoma and adenocarcinoma with ovarian metastasis appears similar based on this cohort.
- Lymphatic spread and transtubal implantation are probable routes for ovarian metastasis, possibly facilitated by corpus involvement.